ShareValue scores for OM: Valuation 61, Quality 59, Growth 39, Health 38.

Outset Medical Inc logo

OM
NASDAQ

Outset Medical Inc

$5.20(+1.56%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

3% to 16%
Valuation
61
Fair Value
Price vs Value
Quality
59
Moderate
Business Strength
Growth
39
Weak
Revenue & Earnings
Health
38
Stressed
Financial Stability
Momentum
35
Bearish
Price Trend

Company Details

About

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026